Journal of Clinical Pediatric Nephrology

Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

Acute Kidney Injury in Hospitalized Children With Cystic Fibrosis


Affiliations
1 University of Alabama School of Medicine, 1720 2nd Avenue South, Birmingham, AL 35294, United States
2 Division of Pediatric Nephrology, Department of Pediatrics, University of Alabama at Birmingham, 1600 7th Avenue, South, Birmingham, AL 35233, United States
     

   Subscribe/Renew Journal


Background: Children hospitalized for cystic fibrosis related pulmonary exacerbation are at risk of acute kidney injury (AKI); yet the incidence of AKI using contemporary definitions has yet to be investigated.

Methods: A retrospective chart review was performed for two eras of about 2 years each. During the former era serum creatinine (SCr) was measured as per clinician. In the latter era, a standardized heightened surveillance program was implemented. Using the 2012 KDIGO AKI definition, we compared the incidence, severity of AKI, hospital costs and length of hospital stay between the two eras.

Results: AKI was more common after surveillance implementation (23.8% vs. 15.2%; p < .001).The number of SCr measurements per each admission was increased in the surveillance era (3.4 ± 5.4 vs. 2.1 ± 2.1; p < .001). Cost and length of stay were highest in those with AKI in the heightened surveillance era (p<0.001).

Conclusions: We found that approximately one-quarter of hospitalized patients with CF will develop AKI. Those with AKI have higher hospital costs and length of stay. Prospective studies to better understand surveillance practices, risk factors, outcomes and strategies to decrease the incidence of AKI are greatly needed.


Keywords

Acute Renal Failure, Aminoglycoside, Nephrotoxicity, Cost, Incidence, Epidemiology.
Subscription Login to verify subscription
User
Notifications
Font Size


Abstract Views: 523

PDF Views: 0




  • Acute Kidney Injury in Hospitalized Children With Cystic Fibrosis

Abstract Views: 523  |  PDF Views: 0

Authors

Adam W. Scott
University of Alabama School of Medicine, 1720 2nd Avenue South, Birmingham, AL 35294, United States
LaCrecia J. Britton
University of Alabama School of Medicine, 1720 2nd Avenue South, Birmingham, AL 35294, United States
Neha Patil
University of Alabama School of Medicine, 1720 2nd Avenue South, Birmingham, AL 35294, United States
Rajesh Koralkar
University of Alabama School of Medicine, 1720 2nd Avenue South, Birmingham, AL 35294, United States
Heather Searcy
University of Alabama School of Medicine, 1720 2nd Avenue South, Birmingham, AL 35294, United States
Raymond Lyrene
University of Alabama School of Medicine, 1720 2nd Avenue South, Birmingham, AL 35294, United States
Tom Harris
University of Alabama School of Medicine, 1720 2nd Avenue South, Birmingham, AL 35294, United States
Hector Gutierrez
University of Alabama School of Medicine, 1720 2nd Avenue South, Birmingham, AL 35294, United States
David Askenazi
Division of Pediatric Nephrology, Department of Pediatrics, University of Alabama at Birmingham, 1600 7th Avenue, South, Birmingham, AL 35233, United States

Abstract


Background: Children hospitalized for cystic fibrosis related pulmonary exacerbation are at risk of acute kidney injury (AKI); yet the incidence of AKI using contemporary definitions has yet to be investigated.

Methods: A retrospective chart review was performed for two eras of about 2 years each. During the former era serum creatinine (SCr) was measured as per clinician. In the latter era, a standardized heightened surveillance program was implemented. Using the 2012 KDIGO AKI definition, we compared the incidence, severity of AKI, hospital costs and length of hospital stay between the two eras.

Results: AKI was more common after surveillance implementation (23.8% vs. 15.2%; p < .001).The number of SCr measurements per each admission was increased in the surveillance era (3.4 ± 5.4 vs. 2.1 ± 2.1; p < .001). Cost and length of stay were highest in those with AKI in the heightened surveillance era (p<0.001).

Conclusions: We found that approximately one-quarter of hospitalized patients with CF will develop AKI. Those with AKI have higher hospital costs and length of stay. Prospective studies to better understand surveillance practices, risk factors, outcomes and strategies to decrease the incidence of AKI are greatly needed.


Keywords


Acute Renal Failure, Aminoglycoside, Nephrotoxicity, Cost, Incidence, Epidemiology.



DOI: https://doi.org/10.15401/jcpn%2F2014%2Fv2i2%2F66337